*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************
Hello everyone,
We invite you to attend the first of a series of seminars with clinicians who can help us bridge the gap in research between PhD students and themselves. This is a great opportunity for anyone interested in pursuing translational research. It is going to be an interactive session, so don't miss out on it!!!
'Research Conversations with Clinicians' seminar series:
"A Clinician's Perspective of a Cancer Problem: We Need Your Help"
Dr. Lechowicz discusses how to approach a cancer problem based on the three phases of clinical trials.
Speaker Bio:
Dr. Lechowicz received her B.A. from Hofstra University, Hempstead, New York with the distinction of cum laude. She then earned her M.D. from the State University of New York in Syracuse, New York where she ranked third clinically in her third and fourth year. Dr. Lechowicz completed her internship, residency, and chief residency at Columbia Presbyterian Medical Center in New York, New York. She went on to complete a fellowship in oncology at the Sidney Kimmel Cancer Center at Johns Hopkins in Baltimore, Maryland. Dr. Lechowicz joined the Winship Cancer Institute in July of 2003.
Dr. Lechowicz’s research focuses on novel therapies for Hodgkin’s and Non Hodgkin’s Lymphomas specifically cutaneous and peripheral T-cell lymphomas. Her interest in HIV and malignancies began with her training at Johns Hopkins. Dr. Lechowicz is the primary investigator for 14 trials at Emory University with regard to improvement of care in non-Hodgkin’s lymphomas, particularly related to transplantation and diffused B-cell lymphomas; cutaneous and peripheral lymphomas; T-cell lymphomas; and HIV and lymphoma care.
Refreshments will be provided.
Thanks,
BBUGS Research Committee